KALARIS THERAPEUTICS, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- KALARIS THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-06-30 was $21.00K, a 93.33% decline year-over-year.
- KALARIS THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2023-06-30 was $315.00K, a 29.10% increase year-over-year.
- KALARIS THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2022-06-30 was $244.00K.
- KALARIS THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $21.00K, a 93.56% decline from fiscal 2023.
- KALARIS THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $326.00K, a 39.18% decline from fiscal 2022.
- KALARIS THERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $536.00K.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2024-12-31 | $21.00K 10-K · filed 2025-03-07 | |
| 2024-06-30 | $21.00K 10-Q · filed 2024-11-12 | |
| 2023-12-31 | $326.00K 10-K · filed 2025-03-07 | |
| 2023-06-30 | $315.00K 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $536.00K 10-K · filed 2024-03-15 | |
| 2022-06-30 | $244.00K 10-Q · filed 2023-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |